Leiden University Scholarly Publications

Search results

  • RSS Feed
(1 - 20 of 20)
Strong CD8+lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer
10-year follow-up and biomarker discovery for adjuvant endocrine therapy; results of the TEAM trial
The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis
The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis
The clinical prognostic value of molecular intrinsic tumor subtypes in older breast cancer patients: A FOCUS study analysis
Validity of the online PREDICT tool in older patients with breast cancer: a population-based study
Tumour immune subtyping as a predictive biomarker for adjuvant endocrine therapy in early breast cancer
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
Contralateral breast cancer risk in relation to tumor morphology and age-in which patients is preoperative MRI justified?
DIFFERENT TUMOR BIOLOGY IN RUSSIAN AND DUTCH PATIENTS WITH BREAST CANCER STAGE I
OPINION How does genome sequencing impact surgery?
Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study
Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis
The prognostic value of apoptotic and proliferative markers in breast cancer
Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patients
Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patients
Clinical prognostic value of HLA-E and HLA-G expression in early breast cancer
Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma